LYVE-1 immunohistochemical assessment of lymphangiogenesis in endometrial and lung cancer.
about
The role of the lymphatic system in endometriosis: a comprehensive review of the literatureThe production of alpha/beta and gamma/delta double negative (DN) T-cells and their role in the maintenance of pregnancyNew horizons for imaging lymphatic function.High density of peritumoral lymphatic vessels is a potential prognostic marker of endometrial carcinoma: a clinical immunohistochemical method studyThe hidden maternal-fetal interface: events involving the lymphoid organs in maternal-fetal tolerance.Vascular endothelial growth factor-D over-expressing tumor cells induce differential effects on uterine vasculature in a mouse model of endometrial cancerLymphatics in lung disease.Post-mastectomy benign lymphangioendothelioma of the skin following chronic lymphedema for breast carcinoma: a teaching case mimicking low-grade angiosarcoma and masquerading as Stewart-Treves syndromeExpressions of COX-2 and VEGF-C in gastric cancer: correlations with lymphangiogenesis and prognostic implicationsCytotrophoblast induction of arterial apoptosis and lymphangiogenesis in an in vivo model of human placentationComparison of the blood and lymphatic microvessel density of pleomorphic adenoma and Basal cell adenoma.Lymphatic vascular density and lymphangiogenesis during tumour progression of carcinoma ex pleomorphic adenoma.Phenotype of tumor lymphatic vessels is a prognostic factor in human tongue squamous cell carcinoma.Vascular Notch proteins and Notch signaling in the peri-implantation mouse uterus.Lymphangiogenesis and expression of specific molecules as lymphatic endothelial cell markers.Induction of lymphangiogenesis in and around axillary lymph node metastases of patients with breast cancerFirst international consensus on the methodology of lymphangiogenesis quantification in solid human tumours.Lymphatic vessel dynamics in the uterine wall.Morphometry analysis of lymphatics in pulmonary adenocarcinomas with a lepidic growth patternDetection of lymphangiogenesis in non-small cell lung cancer and its prognostic value.Endometrial angiogenesis, vascular maturation, and lymphangiogenesis.The endometrial lymphatic vasculature: function and dysfunction.Clinical usefulness of D2-40 in non-small cell lung cancer.The significance of lymphatic space invasion and its association with vascular endothelial growth factor-C expression in ovarian cancer.Metabolic cooperation between co-cultured lung cancer cells and lung fibroblasts.Uterine natural killer cells and angiogenesis in recurrent reproductive failure.Lymphatic vessel density in pulmonary adenocarcinoma immunohistochemically evaluated with anti-podoplanin or anti-D2-40 antibody is correlated with lymphatic invasion or lymph node metastases.Lymphatics-associated genes are downregulated at transcription level in non-small cell lung cancer.
P2860
Q27027943-14DDCBC8-862E-45A3-BF0F-2FED3D2A64D4Q28087072-43D818FC-A28E-4F6D-A69D-91804BE594F5Q30475486-E6EF052A-38A3-4A75-8A8A-E4A78D8F37AAQ33550623-270CC56F-8722-4240-83B5-1FEE9AC89EF7Q33756987-582EDAEA-28FB-4A1F-9BC0-083FFB747AA3Q34016911-49B936D4-EBF5-454E-BFCC-DB98EB3A0500Q34160672-6D60AF31-706D-4FA5-8D8C-C16A03E628EBQ34429863-03687E61-5785-4B60-BBA4-9F76B9A311EAQ34567287-EDE37F35-3D2D-4DF2-B7F5-E9781DBE96FCQ35039896-AA0936B6-AC97-4E24-BFBA-D109CB394347Q35509335-8C1EA1CC-6D52-41B9-8706-69886ED1E36DQ35984450-CB591012-EC02-466C-968F-F9588A9084FBQ36142352-A0B01F2F-92A0-4A02-BB3B-68C299827B0EQ36337071-BFE4962A-DAFB-488C-8471-2146A139B9FEQ36519259-6580559A-2D5F-4851-8033-9A0279502B7BQ36611984-C69885DE-F63A-43CA-80F4-46A6B3DDCD55Q36612618-830CB659-EAF9-49D5-B56F-D14FE33E429BQ36732281-CDD5341A-851A-4769-9296-B8523527664AQ37047641-3C5ABA3C-8D5F-4F95-80DD-F5D5FB4E7ADAQ37109977-D74BC1AB-9527-4331-8A92-24C10B385686Q37323051-CD5A038F-9346-4947-90A8-FBAEB83505A7Q38051130-1EA6A0BE-1DAE-4A63-919F-73A9C1BED778Q38479382-7828C4F1-93C4-4576-AE1F-79BF0B82688AQ38829846-8494BA15-C344-4132-89E3-7040D7C461DCQ47897873-947A8EE0-9E95-42B6-8A9C-EE3292A8B884Q51948319-26148E3E-E59F-4814-A588-5A32AF0F7DA2Q53569737-B5C56A85-9A60-42A6-BBF1-1E3F24A26AAFQ54977595-DFAF2358-F5B1-4D14-A70E-B3E286B79576
P2860
LYVE-1 immunohistochemical assessment of lymphangiogenesis in endometrial and lung cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
LYVE-1 immunohistochemical ass ...... n endometrial and lung cancer.
@ast
LYVE-1 immunohistochemical ass ...... n endometrial and lung cancer.
@en
type
label
LYVE-1 immunohistochemical ass ...... n endometrial and lung cancer.
@ast
LYVE-1 immunohistochemical ass ...... n endometrial and lung cancer.
@en
prefLabel
LYVE-1 immunohistochemical ass ...... n endometrial and lung cancer.
@ast
LYVE-1 immunohistochemical ass ...... n endometrial and lung cancer.
@en
P2093
P2860
P356
P1476
LYVE-1 immunohistochemical assessment of lymphangiogenesis in endometrial and lung cancer
@en
P2093
A Giatromanolaki
C Simopoulos
D G Jackson
E Sivridis
K C Gatter
M I Koukourakis
P2860
P304
P356
10.1136/JCP.2004.019174
P407
P577
2005-02-01T00:00:00Z